Results 71 to 80 of about 16,088 (196)

Clinical and instrumental features of cardiorenal syndrome in cats with hypertrophic cardiomyopathy

RUDN Journal of Agronomy and Animal Industries
This research presents novel insights into the temporal dynamics of clinical and instrumental parameters pertaining to the emergence of cardiorenal syndrome in feline patients afflicted with hypertrophic cardiomyopathy.
Varvara M. Byakhova, Olesya A. Petrukhina, Elena A. Notina, Irina A. Bykova   +3 more
doaj   +1 more source

The cardiorenal syndrome

SA Heart Journal, 2017
The progress made in the medical and device therapy of chronic heart failure (CHF) due to left ventricular systolic dysfunction has heralded new problems.
Eric Klug
doaj   +1 more source

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?

Life, 2023
The pathologic triangle formed by chronic heart failure (HF), chronic kidney disease (CKD), and anemia carries high morbidity and mortality rates and decreases quality of life.
Oana Nicoleta Buliga-Finis, Anca Ouatu, Daniela Maria Tanase, Evelina Maria Gosav, Petronela Nicoleta Seritean Isac, Patricia Richter, Ciprian Rezus   +6 more
doaj   +1 more source

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome [PDF]

, 2018
Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvascular dysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction in oxygen and energy supply leads to brain hypoxia and protein misfolding, thereby linking CCH
Capani, Francisco, Herrera, María Inés, Kusnier, Carlos Federico, Luaces, Juan Pablo, Otero-Losada, Matilde Estela, Toro Urrego, Nicolás, Udovin, Lucas   +6 more
core   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

Evidence of Uncoupling between Renal Dysfunction and Injury in Cardiorenal Syndrome: Insights from the BIONICS Study [PDF]

, 2014
Objective: The objective of the study was to assess urinary biomarkers of renal injury for their individual or collective ability to predict Worsening renal function (WRF) in patients with acutely decompensated heart failure (ADHF).
(GREAT), from the Global Research on Acute Conditions Team, Belcher, Arianna, De Berardinis, Benedetta, Di Somma, Salvatore, Femia, Alexandra, Gaggin, Hanna K., Januzzi, James L., Legrand, Matthieu, Magrini, Laura, Mebazaa, Alexandre, Motiwala, Shweta, Sambhare, Rasika, Simon, Mandy, Vaidya, Vishal S., Zancla, Benedetta   +14 more
core   +3 more sources

Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular‐Kidney‐Metabolic Syndrome

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular‐kidney‐metabolic (CKM) syndrome is defined by the pathologic interconnections between obesity, diabetes, chronic kidney disease and cardiovascular disease. An important and underrecognized pathophysiologic factor underlying CKM syndrome is obesity‐induced aldosterone excess.
Evan Zeitler, Klara R. Klein, Ildiko Lingvay, Anthony Pick, Liana K. Billings   +4 more
wiley   +1 more source

Caracterización de los pacientes con síndrome cardiorrenal tipo I y II en diálisis peritoneal en un centro de diálisis en Bogotá [PDF]

, 2017
Introducción: La ICC que deteriora la función renal es denominada SCR. La DP se plantea como alternativa que impacta en la función cardíaca, hospitalización, síntomas e incluso en la mortalidad 3-5 .
Castro Iregui, Margarita, Pineda Ramirez, Roberto   +1 more
core   +1 more source

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims In a phase 2 trial, the efficacy and safety of the highly selective aldosterone synthase inhibitor vicadrostat, alone or with empagliflozin, were investigated in people with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). Materials and Methods Adults (n = 586) with CKD (estimated glomerular filtration rate [eGFR] 30 to
David Z. I. Cherney, Peter Rossing, Maria Eugenia Canziani, Maria Luiza Caramori, Ricardo Correa‐Rotter, Lisa Cronin, Christian Hugo, Bo Ji, Juliane Meyerhoff, Masaomi Nangaku, Arnold Silva, Dorothea Urbach, Shimoli V. Shah, Dick de Zeeuw, Katherine R. Tuttle   +14 more
wiley   +1 more source

Oxidative stress in dogs with cardiorenal syndrome caused by endocardiosis

RUDN Journal of Agronomy and Animal Industries
Oxidative stress and decreased antioxidant defense were registered in dogs with endocardiosis. Complication of underlying pathology in the form of cardiorenal syndrome leads to aggravation of lipid peroxidation processes and causes further decrease in ...
Yuri A. Vatnikov, Andrey A. Rudenko, Igor V. Shchurov, Ilia F. Vilkovyskiy, Evgenia M. Yarovenko   +4 more
doaj   +1 more source